Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Raburn M Mallory"'
Autor:
Bruce K Brown, Josephine Cox, Anita Gillis, Thomas C VanCott, Mary Marovich, Mark Milazzo, Tanya Santelli Antonille, Lindsay Wieczorek, Kelly T McKee, Karen Metcalfe, Raburn M Mallory, Deborah Birx, Victoria R Polonis, Merlin L Robb
Publikováno v:
PLoS ONE, Vol 5, Iss 11, p e13849 (2010)
The fatal disease caused by Bacillus anthracis is preventable with a prophylactic vaccine. The currently available anthrax vaccine requires a lengthy immunization schedule, and simpler and more immunogenic options for protection against anthrax are a
Externí odkaz:
https://doaj.org/article/536b9783e5ae44dbbd58d330690a4703
Autor:
Raburn M Mallory, Elissa Malkin, Christopher S Ambrose, Terramika Bellamy, Li Shi, Tingting Yi, Taff Jones, George Kemble, Filip Dubovsky
Publikováno v:
PLoS ONE, Vol 5, Iss 10, p e13755 (2010)
The safety, tolerability, and immunogenicity of a monovalent intranasal 2009 A/H1N1 live attenuated influenza vaccine (LAIV) were evaluated in children and adults.Two randomized, double-blind, placebo-controlled studies were completed in children (2-
Externí odkaz:
https://doaj.org/article/e256e25f0d854be2ba56ede4a7a43f39
Autor:
Eddie Underwood, Lisa M. Dunkle, Shabir A. Madhi, Cynthia L. Gay, Paul T. Heath, Karen L. Kotloff, Katherine Smith, Gordon Chau, Shirley Galbiati, Alice McGarry, Wayne Woo, Iksung Cho, Katia Alves, Germán Áñez, Chijioke Bennett, Vivek Shinde, Louis Fries, Raburn M. Mallory, Gregory M. Glenn, Seth Toback
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 501-517 (2023)
Introduction The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in significant morbidity and mortality worldwide. As SARS-CoV-2 moves into endemic status, vaccination
Externí odkaz:
https://doaj.org/article/63a46f7f41f7419791219c14242672d7
Autor:
Nita Patel, Jessica F. Trost, Mimi Guebre-Xabier, Haixia Zhou, Jim Norton, Desheng Jiang, Zhaohui Cai, Mingzhu Zhu, Anthony M. Marchese, Ann M. Greene, Raburn M. Mallory, Raj Kalkeri, Filip Dubovsky, Gale Smith
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Monovalent SARS-CoV-2 Prototype (Wuhan-Hu-1) and bivalent (Prototype + BA.4/5) COVID-19 vaccines have demonstrated a waning of vaccine-mediated immunity highlighted by lower neutralizing antibody responses against SARS-CoV-2 Omicron XBB sub-
Externí odkaz:
https://doaj.org/article/ad7456950c5a471aa62cd2ee79cad670
Autor:
Katia Alves, Joyce S. Plested, Shirley Galbiati, Gordon Chau, Shane Cloney-Clark, Mingzhu Zhu, Raj Kalkeri, Nita Patel, Kathy Smith, Alex Marcheschi, Susan Pfeiffer, Heather McFall, Gale Smith, Gregory M. Glenn, Filip Dubovsky, Raburn M. Mallory
Publikováno v:
New England Journal of Medicine. 388:857-859
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d72458360ab8561e0fa81d0fad4dcecf
https://doi.org/10.1056/nejmc2215509
https://doi.org/10.1056/nejmc2215509
Autor:
Seth Toback, Anthony M. Marchese, Brandy Warren, Sondos Ayman, Senka Zarkovic, Islam ElTantawy, Raburn M. Mallory, Matthew Rousculp, Fahed Almarzooqi, Bartlomiej Piechowski-Jozwiak, Maria-Fernanda Bonilla, Agyad Ebrahim Bakkour, Salah Eldin Hussein, Nawal Al Kaabi
This phase 3 observer-blind, randomized, controlled study was conducted in adults ≥18 years of age to assess the safety and immunogenicity of NVX-CoV2373 as a heterologous booster compared to BBIBP-CorV when utilized as a homologous booster. Approx
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f95db6f040696e49e02517b5772c130
https://doi.org/10.1101/2023.03.24.23287658
https://doi.org/10.1101/2023.03.24.23287658
Autor:
Katia Alves, Joyce S Plested, Shirley Galbiati, Gordon Chau, Shane Cloney-Clark, Mingzhu Zhu, Raj Kalkeri, Nita Patel, Kathy Smith, Alex Marcheschi, Susan Pfeiffer, Heather McFall, Gale Smith, Gregory M. Glenn, Filip Dubovsky, Raburn M. Mallory
SummaryBackgroundThe emergence of SARS-CoV-2 variants has significantly reduced the efficacy of some approved vaccines. A fourth dose of NVX-CoV2373 (5µg SARS-CoV-2 rS + 50µg Matrix-M™ adjuvant) was evaluated to determine induction of cross-react
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edae913865e20c7349c5a0b7de47aba8
https://doi.org/10.1101/2022.11.18.22282414
https://doi.org/10.1101/2022.11.18.22282414
Autor:
Raburn M Mallory, Neil Formica, Susan Pfeiffer, Bethanie Wilkinson, Alex Marcheschi, Gary Albert, Heather McFall, Michelle Robinson, Joyce S Plested, Mingzhu Zhu, Shane Cloney-Clark, Bin Zhou, Gordon Chau, Andreana Robertson, Sonia Maciejewski, Holly L Hammond, Lauren Baracco, James Logue, Matthew B Frieman, Gale Smith, Nita Patel, Gregory M Glenn, Mark Adams, Mark Arya, Eugene Athan, Ira Berger, Paul Bradley, Toby Briskin, Richard Glover II, Paul Griffin, Joshua Kim, Scott Kitchener, Terry Klein, Amber Leah, Indika Leelasena, Charlotte Lemech, Jason Lickliter, Mary Beth Manning, Fiona Napier-Flood, Paul Nugent, Susan Thackwray, Mark Turner
Publikováno v:
The Lancet. Infectious diseases. 22(11)
Emerging SARS-CoV-2 variants and evidence of waning vaccine efficacy present substantial obstacles towards controlling the COVID-19 pandemic. Booster doses of SARS-CoV-2 vaccines might address these concerns by amplifying and broadening the immune re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9de8292fa80c9a4a06d0e79ac14652
https://pubmed.ncbi.nlm.nih.gov/35963271
https://pubmed.ncbi.nlm.nih.gov/35963271
Autor:
Richard F. Olsson, Raburn M. Mallory, Vivian H. Shih, Pamela L. Zeitlin, Jeremy Cole, Mitchell Goldman, Mila Leong
Publikováno v:
Journal of Asthma and Allergy
Pamela L Zeitlin,1 Mila Leong,2 Jeremy Cole,3 Raburn M Mallory,4 Vivian H Shih,5 Richard F Olsson,6 Mitchell Goldman5 On behalf of the ALIZE study investigators 1Department of Pediatrics, National Jewish Health, Denver, CO, USA; 2Pediatric Pulmonary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f86b59d3a0a11accde2b1994d2997c7
https://doi.org/10.2147/jaa.s172338
https://doi.org/10.2147/jaa.s172338
Autor:
Ki Rito, Michio Tanaka, Yohji Itoh, Sachiko Kameo, Filip Dubovsky, Raburn M. Mallory, Jing Yu
Publikováno v:
Influenza and Other Respiratory Viruses
Background Quadrivalent live attenuated influenza vaccine (Q/LAIV) has not been assessed in Japanese children. Objectives Evaluate safety and efficacy of Q/LAIV in Japanese children. Patients/methods Two phase 3 studies were conducted in the 2014-201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26033d51098057231407c155f46bdb1f
https://doi.org/10.1111/irv.12555
https://doi.org/10.1111/irv.12555